Chris Price

Chris Price is the Founder and Managing Partner of Epilog Partners a private equity platform built by investors, operators and innovators for healthcare's complexity. It invests in tech-enabled payer and provider services and software and tech-enabled pharma services companies that are improving clinical, financial, and experiential outcomes. Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Its efforts are guided by a research centric, thesis driven approach that informs where to invest and how to maximize value. This approach has resulted in completed platform investments, add-on acquisitions, recapitalizations and liquidity events with an aggregate transaction value of over $6 billion.